PALYNZIQ Solution for injection Ref.[113789] Active ingredients: Pegvaliase

Source: European Medicines Agency (EU)  Revision Year: 2024  Publisher: BioMarin International Limited, Shanbally, Ringaskiddy, County Cork, Ireland, P43 R298

Product name and form

Palynziq 2.5 mg solution for injection in pre-filled syringe.

Palynziq 10 mg solution for injection in pre-filled syringe.

Palynziq 20 mg solution for injection in pre-filled syringe.

Pharmaceutical Form

Solution for injection (injection).

Colourless to pale yellow, clear to slightly opalescent solution with pH 6.6 – 7.4.

2.5 mg pre-filled syringe:

Osmolality: 260 – 290 mOsm/kg.

10 mg and 20 mg pre-filled syringe:

Osmolality: 285 – 315 mOsm/kg, viscous solution.

Qualitative and quantitative composition

Each 2.5 mg pre-filled syringe contains 2.5 mg pegvaliase in 0.5 ml solution.

Each 10 mg pre-filled syringe contains 10 mg pegvaliase in 0.5 ml solution.

Each 20 mg pre-filled syringe contains 20 mg pegvaliase in 1 ml solution.

The strength indicates the quantity of the phenylalanine ammonia lyase (rAvPAL) moiety of pegvaliase without consideration of the PEGylation.

The active substance is a covalent conjugate of the protein phenylalanine ammonia lyase (rAvPAL)* with NHS-methoxypolyethylene glycol (NHS-PEG).

* Anabaena variabilis rAvPAL produced by recombinant DNA technology in Escherichia coli.

The potency of this medicinal product should not be compared to any other PEGylated or non-PEGylated protein of the same therapeutic class. For more information, see section 5.1.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Pegvaliase

Pegvaliase is a PEGylated recombinant phenylalanine ammonia lyase enzyme that converts phenylalanine to ammonia and trans-cinnamic acid that are primarily eliminated by liver metabolism.

List of Excipients

Trometamol
Trometamol hydrochloride
Sodium chloride
trans-cinnamic acid
Water for injections

Pack sizes and marketing

1 ml pre-filled syringe made of Type I borosilicate glass, equipped with a stainless steel 26 gauge needle, needle safety device, polypropylene plunger rod, and chlorobutyl or bromobutyl rubber syringe stopper with fluoropolymer coating. The automatic needle guard is composed of a polycarbonate transparent needle guard and a stainless steel spring inside the needle guard. After injection, the spring expands causing the needle to be covered by the needle guard.

Pre-filled syringe 2.5 mg (white plunger):

Each carton contains 1 pre-filled syringe.

Pre-filled syringe 10 mg (green plunger):

Each carton contains 1 pre-filled syringe.

Pre-filled syringe 20 mg (blue plunger):

Each carton contains 1 or 10 pre-filled syringes.

Not all pack sizes may be marketed.

Marketing authorization holder

BioMarin International Limited, Shanbally, Ringaskiddy, County Cork, Ireland, P43 R298

Marketing authorization dates and numbers

EU/1/19/1362/001 1 × 2.5 mg pre-filled syringe
EU/1/19/1362/002 1 × 10 mg pre-filled syringe
EU/1/19/1362/003 1 × 20 mg pre-filled syringe
EU/1/19/1362/004 10 × 20 mg pre-filled syringes

Date of first authorisation: 03 May 2019

Drugs

Drug Countries
PALYNZIQ Austria, Estonia, France, Croatia, Ireland, Italy, Japan, Lithuania, Poland, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.